chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received 1st dose 1/28/2021 at 8:30pm.  On 1/29/21 at 4:30 patient experienced headache, urinary incontinence, body ache , dizziness, and chills. Symptoms lasted 24 hours. Second dose administered 3/5/2021
Pt. (L) arm above elbow with 7cm x 7cm redness patchy, not raised. No pain. Minimal bruising, minimal itch. No swelling, no fever, no chills.
Rph administered expired vaccine because she misunderstood the time of expiration after the update indicating that it is good for 30 days.  She thought it is good for punctured one as well.  Pharmacy manager wasn't sure either. We have to find out from DM since the pharmacy manager wasn't sure.
Narrative: Pt is a 75y.o. male who died on 04/23/2021 w/ h/o Superior mesenteric vein thrombosis, Malignant tumor of pancreas, T2DM, CAD, COPD. Pt received Moderna Covid-19 Vaccination 2/2 on 02/13/2021. Unlikley that Moderna Covid-19 Vaccine caused/contributed pt death.
Patient sat in the observation area for 15 minutes following the administration. Once he started to get up to go home he passed out in his chair and fell to the floor
Information has been received from a physician concerning a 11 year old female patient with no pertinent medical history and no known drug reactions or allergies, who on 23-MAR-2010, was vaccinated intramuscularly with the first 0.5 mL dose of GARDASIL (lot number 661954/0075Y) (Expiration date 15-MAR-2011). Concomitant therapy included FLONASE. On 26-MAY-2010, the patient received intramuscularly the second 0.5 mL dose of GARDASIL (lot number not specified). The physician reported that the patient experienced vomiting, dizziness, headache, fever and abdominal pain after receiving both doses of GARDASIL. The patient sought unspecified medical attention. No lab diagnostics studies were performed. The patient recovered after each dose (dates not provided). Additional information has been requested.
I was pregnant when I received my second dose of the Covid-19 Pfizer vaccine. My first Covid 19 vaccine was administered 12/28/2020.  I got pregnant on 12/31/2020, received my second dose on 01/18/2021 and miscarried on 2/25/2021. I have had two prior uncomplicated pregnancies, and have never experienced a miscarriage. I gave birth to my two daughters, one at 42 weeks and one at 40 weeks and 5 days.  My EDD for the pregnancy that ended in a miscarriage was due 09/23/2021.
was given Pfizer-BioNTech COVID-19  in right arm duty  1. within 2 minutes of shot, my throat began closing and lasted 20 minutes 2. next morning I awakened with right hand severely contracted and had a tingling sensation; I forced my hand to open and close to relieve contraction 3. .then all  day, I lost control of my bladder and had to use several pads to catch the  flowing urine;
flu; got sick as fuck; Based on additional information received on 22-Oct-2020, the case was initially considered as non valid was updated to valid case due to addition of influenza vaccine as the suspect product.  Initial information regarding an unsolicited non-valid non-serious case received from a consumer (patient) via social media and was transmitted to Sanofi on 28-Sep-2020.  This case was linked to case 2020SA295897, 2020SA299080, 2020SA299167, 2020SA299168, 2020SA299171, 2020SA299170, 2020SA299169 (cluster).  This case involves a patient of unknown demographics who had flu (Influenza) and got sick (Malaise), while the patient received INFLUENZA VACCINE.  Medical history, past medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were unknown.  On an unknown date (reported as two years ago), the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer via unknown route at an unknown administration site (lot number and expiry date not reported) for prophylactic vaccination.  On an unknown date, (unknown latency) the patient developed a non-serious flu (influenza) and got really sick (illness) following administration of INFLUENZA VACCINE .  No laboratory data was reported.  Corrective treatment and event outcome were unknown.  There will be no information available on batch number for the case.  Additional information regarding the valid non-serious case was received on 22-Oct-2020 from a consumer (patient) via social media.  Case was updated to valid due to addition of influenza vaccine as the suspect. Event flu was added. Action taken, as reported term of event sickness and company causality were amended from the previous version. Corresponding fields and narrative were updated accordingly.
Patient vaccinated x2 (Moderna): 01/30/2021, 03/19/2021  Patient hospitalized and tested positive for COVID19 on 03/15/2022
Pfizer 2nd dose.. stared with tinging in eyelids, 30 seconds of tingling in arms, tingling in lower legs, blood pressure was low100/61(took blood pressure twice). After calling paramedics, discoloration in face, also felt like he was going to pass out.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 65-year-old female patient who received SHINGRIX for prophylaxis. On 4th August 2018, the patient received the 1st dose of SHINGRIX. On 4th August 2018, less than a day after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The patient experienced flu like symptoms. For tolerance after 2nd dose, refer case US2019GSK070470.
Fever up to 101.9, severe body aches, headache, fatigue, chills/sweats. Tylenol Extra Strength and rest.  About 24 hours later all symptoms resolved.
Nausea; aches; sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) received via COVID-19 Adverse Event Self-Reporting Solution. The reporter is the patient.   A 52-year-old male patient received BNT162b2 (BNT162B2), on 07Apr2022 as dose 4 (booster) single (Lot number: FH8027) at the age of 52 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Sulfa" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Cipro, reaction(s): "Allergy to Cipro". Vaccination history included: Covid-19 vaccine (Dose: 1, MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (Dose: 2, MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (Dose: 3, MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: NAUSEA (non-serious) with onset 08Apr2022, outcome "recovered" (Apr2022); PAIN (non-serious) with onset 08Apr2022, outcome "recovered" (Apr2022), described as "aches"; PAIN IN EXTREMITY (non-serious) with onset 08Apr2022, outcome "recovered" (Apr2022), described as "sore arm". Therapeutic measures were not taken as a result of nausea, pain, pain in extremity.  Additional information: Patient did not receive other vaccine in four weeks. Patient had no COVID prior vaccination and was not COVID tested post vaccination.
two days ago the soreness around the shot area came back; red around the top of the arm; there is a rash; first day she had sore arm and it was warm around the area but then went away/kind of feels warm; first day she had sore arm and it was warm around the area but then went away; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (first day she had sore arm and it was warm around the area but then went away), VACCINATION SITE PAIN (two days ago the soreness around the shot area came back), ERYTHEMA (red around the top of the arm), RASH (there is a rash) and VACCINATION SITE WARMTH (first day she had sore arm and it was warm around the area but then went away/kind of feels warm) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced PAIN IN EXTREMITY (first day she had sore arm and it was warm around the area but then went away). On 12-May-2021, the patient experienced VACCINATION SITE PAIN (two days ago the soreness around the shot area came back), ERYTHEMA (red around the top of the arm), RASH (there is a rash) and VACCINATION SITE WARMTH (first day she had sore arm and it was warm around the area but then went away/kind of feels warm). On 05-May-2021, PAIN IN EXTREMITY (first day she had sore arm and it was warm around the area but then went away) had resolved. At the time of the report, VACCINATION SITE PAIN (two days ago the soreness around the shot area came back), ERYTHEMA (red around the top of the arm), RASH (there is a rash) and VACCINATION SITE WARMTH (first day she had sore arm and it was warm around the area but then went away/kind of feels warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that she used wrap around the injection site. No concomitant medications were not provided.  Treatment medications were not provided.     This case was linked to US-MODERNATX, INC.-MOD-2021-134516 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-134516:Husband case
This case was reported by a consumer via call center representative and described the occurrence of pain in a 70-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included ZOSTAVAX (dose received on an unknown date). On 26th June 2018 16:00, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than 3 months after receiving SHINGRIX, the patient experienced pain and headache. On an unknown date, the outcome of the pain and headache were recovered/resolved. It was unknown if the reporter considered the pain and headache to be related to SHINGRIX. Additional information received as follows: The patient reported that she received SHINGRIX on the left deltoid. The patient experienced feeling achy and having a headache for a couple of days. The contact details of the physician were provided. For tolerance to next dose, refer case US2018GSK171866. This case was linked to the case US2018166447, reported by the same reporter (the reporter's mother case).
Patient developed a full body rash within a week of receiving this vaccine.   MD ruled out vasculitis and did some blood work.  Rash lasted months and patient took zyrtec for a few weeks after rash developed.
6 hours post injection increasingly severe fever, shaking chills, nausea, malaise lasting about 6 hours. 4 days later another episode of shaking chills lasting 2 hours.
Developed swelling and pain in the shoulder area after immunization. Two days post immunization, developed vesiculopapular rash on left shoulder that has spread down the arm.
increase in peripheral neuropathy; sore left arm; Daily since then have had worsening symptoms until much of the day I'm now unable to walk.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Jan2022 12:00 (Lot number: FJ1614) at the age of 63 years as dose 3 (booster), single for covid-19 immunization. Relevant medical history included: "Parkinson's" (unspecified if ongoing); "if covid prior vaccination: Yes" (unspecified if ongoing). Concomitant medication(s) included: SINEMET CR; XANAX; BACLOFEN; CLONAZEPAM. Past drug history included: Pineapple, reaction(s): "Known allergies: Pineapple". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: ER8731), administration date: 11Apr2021, when the patient was 62 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8727), administration date: 21Mar2021, when the patient was 62 years old, for COVID-19 Immunization. The patient did not receive any other vaccine in four weeks of covid vaccine. The patient was not tested for covid post vaccination.  The following information was reported: NEUROPATHY PERIPHERAL (disability, medically significant) with onset 25Jan2022, outcome "not recovered", described as "increase in peripheral neuropathy"; PAIN IN EXTREMITY (disability) with onset 24Jan2022 06:00, outcome "not recovered", described as "sore left arm"; GAIT INABILITY (disability) with onset 2022, outcome "not recovered", described as "Daily since then have had worsening symptoms until much of the day I'm now unable to walk.". The events "increase in peripheral neuropathy", "sore left arm" and "daily since then have had worsening symptoms until much of the day i'm now unable to walk." were evaluated at the physician office visit. Therapeutic measures were not taken as a result of neuropathy peripheral, pain in extremity, gait inability.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200313644 Same patient and drug, different event separated in time
About 3 weeks after the vaccine I started having severe chest and belly aches on the right side. CT scan showed a blood clot on my lungs and pneumonia
Caller c/o hot flashes twice a day since receiving the vaccine on 3/13, states that her skin feels "hot", however reports no fever. Takes cool showers to feel better. No other symptoms
Consumer is pregnant and received the Adacel vaccine, no AE; Initial information received on 27-Aug-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves female patient of an unknown age who was received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (batch number, expiry date, dose, route and site of administration were unknown) on an unspecified date, while she was pregnant.  Data regarding this pregnancy were received prospectively i.e. before pregnancy outcome was known.  The date of last menstrual period was not reported.  The estimated due date is 27-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Reporter did not know the dose. She did not receive any other medication or vaccinations.  It was case of vaccine exposure during pregnancy. The patient was pregnant when she received vaccine.  It was unknown whether patient experienced any adverse reaction after the injection.  Pregnancy outcome was unknown at the time of report.  Information on the batch number was requested.  List of documents held by sender- none.
fatigue; Body ache/aches; injection site was very painful/tenderness at injection site; low grade fever; soreness on day of injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness on day of injection), MYALGIA (Body ache/aches), VACCINATION SITE PAIN (injection site was very painful/tenderness at injection site), PYREXIA (low grade fever) and FATIGUE (fatigue) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN (soreness on day of injection). On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (injection site was very painful/tenderness at injection site) and PYREXIA (low grade fever). On 10-Feb-2021, the patient experienced MYALGIA (Body ache/aches). On 11-Feb-2021, the patient experienced FATIGUE (fatigue). At the time of the report, PAIN (soreness on day of injection), MYALGIA (Body ache/aches), VACCINATION SITE PAIN (injection site was very painful/tenderness at injection site), PYREXIA (low grade fever) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No Treatment information was reported.   This case was linked to MOD-2021-047928 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Event duration updated. Further follow-up denied.
APR92 recvd 1 dose of Engerix-B & H-BIG p/suffering a needle stick; liver felt sore 4 days afterwards;
Two days after receiving my second Phozer shot, my scalp experiences a strong itch. A few days after, hives are visible all over my torso, neck, and arms. Looks like rash, severe itch. Flares up through the day. 3 weeks later I still experience very itchy hives, arguably getting worse.
Late onset ..day 8 after injection..localized site reaction so far with redness size of tennis ball and severe itching.
No Adverse Event; HCP reported patient was accidently administered an expired dose of MMR II on Jun 7, 2023. Product expired on Apr 15, 2023. Product had no prior temperature excursions. No further information provided. No additional AE reported. No PQC reported.; This spontaneous report was received from medical assistant refers to a 2-year-old female patient.    The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 07-JUN-2023, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, rHA (recombinant Human albumin) (M-M-R II) lot #U011995, expiration date: 15-APR-2023 for prophylaxis (expired product administered). There were no additional adverse events reported (no adverse event).
Information has been received from a health professional concerning a 5 year old male (also reported as 12 month old) pt who on 3/20/01 was vaccinated SC in the right arm, with a 2nd dose of MMRII (lot 636974/1280K), a 5th dose in the left arm of Tripedia (batch U0320AB), a 5th dose in the right arm of poliovirus (IPOL) (batch T0395) and a 1st dose in the left arm of varicella virus vaccine (Varivax) (lot 1670K, invalid lot for this product). It was reported that 1 month later, on 4/5/01 (also reported as 4/15/01), the pt was dx'd with ITP (idiopathic thrombocytopenic purpura). On 4/5/01 (also reported as 4/15/01), the child's platelets were 25,000. It was noted that the bone marrow count done on 7/9/01 was consistent with ITP. It was also noted that the pt had 'multiple bruising' for 3 weeks and that his count on 12/14/01 was 77,000. It was reported that the pt has not recovered. Unspecified medical attention was sought. Another pt (WAES01110807) had a similar experience after vaccination with MMRII (lot 636975/1280K). Upon internal review, ITP was considered to be an "Other Important Medical Event". Additional information has been requested.
he had two diarrhea episodes and the third day one episode so far; This is a spontaneous report from a contactable Physician. A 14-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via intramuscular route of administration in left arm on 26Jun2021 at 14:30 (at the age of 14 years old) as dose 1, single for covid-19 immunisation. Medical history included rare epilepsy, developmental delay, hypotonia. The patient had known allergies to penicillin, pneumococcal vaccine. Concomitant medication included ibuprofen (ADVIL 12 HOUR), 200 mg once time. The patient did not receive any other vaccines within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 28Jun2021 at 12:00 second day post vaccination he had two diarrhea episodes and the third day one episode so far. Therapeutic measures were taken as a result of he had two diarrhea episodes and the third day one episode so far with pedialyte and probiotics. The outcome of events was recovering.  Follow-up attempts completed. No further information expected.
Booster received on Oct 30, 2021. On Nov 11, 2021, had a stroke. Have aphasia, and word retrieval issues.
Patient was in for a well child check, pt needed 2 month shots. PREVNAR and HIB were administered on right thigh. Which after a couple of hours started getting a bright red streak lateral line. Pts mother stated Pt had a fever and vomit until the following day and went away afterwards. Per PA-C rash is not systemically but locally. Cetirizine 1mg everyday with cold compresses on area were recommended if it does not get any better, patient needs to come back in to see provider.
fatigued; aching; This is a spontaneous report from a non-contactable consumer (patient). A adult female patient received the first dose and second dose of bnt162b2 (Lot/batch number and Expiration date were not provided), all via an unspecified route of administration on an unspecified dates at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient felt fatigued and had aching for several hours after the vaccine was given. Patient was no pregnant. The outcome of the events was recovered on unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recvd vax; exp high fever & sz; reporter believes pt exp sz but not 100 percent sure
Flu vaccine 06Oct2023 / Pfizer 06Oct2023; Flu vaccine 06Oct2023 / Pfizer 06Oct2023; Extreme itchiness at injection site; major body aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 70-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 06Oct2023 at 13:00 as dose 4, single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), on 06Oct2023 as dose number, unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 3 ; Manufacture Unknown), for Covid-19 immunization; Covid-19 vaccine (Dose 2 ; Manufacture Unknown), for Covid-19 immunization; Covid-19 vaccine (Dose 1 ; Manufacture Unknown), for Covid-19 immunization. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 06Oct2023, outcome "unknown" and all described as "Flu vaccine 06Oct2023 / Pfizer 06Oct2023"; VACCINATION SITE PRURITUS (non-serious) with onset Oct2023, outcome "recovering", described as "Extreme itchiness at injection site"; PAIN (non-serious) with onset Oct2023, outcome "recovering", described as "major body aches". It was unknown if therapeutic measures were taken as a result of vaccination site pruritus, pain.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Extreme muscle pain, mild joint pain, moderate to severe nausea, vomiting, vomited blood, dizziness, numbness in limbs, cold sweats, near fainting several times, moderate weakness, moderate fatigue, unable to sleep.
Note: Had no tachycardia prior to getting COVID-19 vaccines (2-step). 1st dose on 4/15 and 2nd dose 5/6. Onset of tachycardia, now episodic heart rate is 100 and over. Hypertension not controlled. Had to visit local ER hospital on 5/5 with "palpitations and tachycardia."
At time of shot, I was 23 weeks pregnant. This is my third pregnancy, no issues thus far in pregnancy or any previous.   At roughly 9:30am the day after the shot was administered (roughly 18 hours after) I begin to get full body aches, strong headaches, joint pain, and a low grade fever. This persisted until around 7am the next morning.
left arm and hand are not working properly from typing to buttoning shirts, tying shoes, etc.
Patient received 2 vaccines in her right arm. It was sore later that day and continued to worsen into the next day. She went to the ER on 9/16/17 and received pain med and a sling to wear.